Amundi’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,323
Closed -$14.3K 2038
2023
Q3
$14.3K Sell
2,323
-12,357
-84% -$100K ﹤0.01% 1961
2023
Q2
$131K Hold
14,680
﹤0.01% 1710
2023
Q1
$115K Sell
14,680
-4,396
-23% -$24.4K ﹤0.01% 1705
2022
Q4
$97.1K Sell
19,076
-1,051
-5% -$6.5K ﹤0.01% 1614
2022
Q3
$153K Hold
20,127
﹤0.01% 1488
2022
Q2
$112K Buy
20,127
+4,415
+28% +$33.8K ﹤0.01% 1429
2022
Q1
$156K Buy
+15,712
New +$138K ﹤0.01% 1413

Other funds holding LFST

Amundi's LFST Position: Q4 2023 in Review

Amundi sold out of Lifestance Health (LFST) in Q4 2023, closing a stake of 2,323 shares — an estimated $14.3K sold.

Amundi first reported a position in LFST in Q1 2022 and held it in 7 quarters. The position peaked at $156K in Q1 2022. 120 funds tracked by Wall St. Rank hold LFST as of Q4 2023.

  • Amundi reported no remaining Lifestance Health position as of Q4 2023 after selling out during the quarter.
  • Amundi sold 2,323 Lifestance Health shares in Q4 2023, an estimated $14.3K.
  • Amundi first reported a position in Lifestance Health in Q1 2022 and held it in 7 quarters.
  • Amundi's Lifestance Health position peaked at $156K in Q1 2022.
  • 120 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2023.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.